About Shan Xiang Wang
Form D filings for Curve Biosciences in 2024 list Shan Xiang Wang as executive officer and director.
Shan Xiang Wang first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Shan Xiang Wang in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Shan Xiang Wang works with at each company, as listed on that company's latest Form D.
Curve Biosciences, Inc. · Form D, May 13, 2024
CO
Chuba Oyolu
Executive officer
NH
Nathan Hunkapiller
Executive officer
TK
Themasap Khan
Director
RP
Ritish Patnaik
Chief Executive Officer and director